| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/28/2010 | CA2731451A1 Pyrazolopyridine kinase inhibitors |
| 01/28/2010 | CA2731432A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | CA2730762A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/28/2010 | CA2730757A1 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 01/27/2010 | EP2147914A1 Aminodihydrothiazine derivatives substituted with cyclic groups |
| 01/27/2010 | EP2146993A2 A method for the preparation of mirtazapine |
| 01/27/2010 | EP2146991A2 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/27/2010 | EP2146989A1 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases |
| 01/27/2010 | EP2146988A1 New 4,8-diphenyl-polyazanaphthalene derivatives |
| 01/27/2010 | EP2146986A1 Diphenyl-dihydro-imidazopyridinones |
| 01/27/2010 | EP2146969A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptor-5 |
| 01/27/2010 | EP2146964A2 Ethers of naphtalene carboxylic acid amides as cancer cure |
| 01/27/2010 | EP2146720A1 Aryloxy-and heteroaryloxy-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/27/2010 | EP2146715A1 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamate and urea end groups |
| 01/27/2010 | EP2146712A1 Aryl heterocyclic cgrp receptor antagonists |
| 01/27/2010 | EP2146572A1 Bicyclic anilide heterocyclic cgrp receptor antagonists |
| 01/27/2010 | EP2044051B1 Pyridine and pyrazine derivatives as mnk kinase inhibitors |
| 01/27/2010 | EP1656353B1 Gabanergic modulators |
| 01/27/2010 | CN101636399A Substituted pyrimidodiazepines useful as PLK1 inhibitors |
| 01/27/2010 | CN101636398A Pyridopyrimidinone compounds useful in treating sodium channel-mediated diseases or conditions |
| 01/27/2010 | CN101632663A Novel molecular target for neurotoxicity |
| 01/27/2010 | CN100586244C Compound, charge transporting material and organic electroluminescent element |
| 01/27/2010 | CN100584843C Substituted diaza-spiro-[5.5|-undecane derivatives and their use as neurokinin antagonists |
| 01/26/2010 | US7652141 Immunosuppressants, analgesics, antiinflammatory agents |
| 01/26/2010 | US7652137 Substitued azaindoline intermediate for use in the manufacture of 5-substituted 7-azaindolines and 5-substituted 7-azaindoles; pharmaceutical intermediates |
| 01/26/2010 | US7652132 Implementation of a strategy for achieving extraordinary levels of surface area and porosity in crystals |
| 01/26/2010 | US7652035 CRF receptor antagonists and methods relating thereto |
| 01/26/2010 | US7652034 Enantiomer (-) of tenatoprazole and the therapeutic use thereof |
| 01/26/2010 | US7652027 Phenanthroindolizidine alkaloids |
| 01/26/2010 | US7652021 (2S)-4,4-difluoro-1-{N-[3-(pyrimidin-2-ylamino)-1-adamantyl]glycyl}pyrrolidine-2-carbonitrile; dipeptidyl peptidase IV enzyme inhibitors; non-insulin dependent diabetes mellitus |
| 01/26/2010 | US7652020 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 01/26/2010 | US7652005 Tricyclic δ-opioid modulators |
| 01/26/2010 | CA2470064C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 01/26/2010 | CA2447099C Delivery of compounds for the treatment of migraine through an inhalation route |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/26/2010 | CA2275345C Pro-drugs and counterparts of camptothecin, their application as medicines |
| 01/21/2010 | WO2010009290A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | WO2010009212A1 Niacin derivatives useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009195A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 01/21/2010 | WO2010009155A2 Fused heterocyclyc inhibitor compounds |
| 01/21/2010 | WO2010008832A1 Pyrrolo-pyridine-3-yl-piperazine derivatives having 5-ht6 receptor affinity |
| 01/21/2010 | WO2010008775A1 Aminopyridopyrazinone derivatives for treating neurodegenerative diseases |
| 01/21/2010 | WO2010007944A1 Nitrogenated bicyclic heterocyclic compound |
| 01/21/2010 | WO2010007794A1 Novel spiro compound, and pharmaceutical preparation comprising the same |
| 01/21/2010 | WO2010007318A2 Novel imidazo[1,2-a]pyrimidine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010007317A1 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2010007248A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | WO2010007120A1 Pyridazine derivatives as smo inhibitors |
| 01/21/2010 | WO2010007114A2 New chemical compounds |
| 01/21/2010 | WO2010007100A1 7-substituted amino triazoles as pi3k inhibitors |
| 01/21/2010 | WO2010006947A1 Novel phenyl-imidazopyridines and pyridazines |
| 01/21/2010 | WO2010006945A1 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | WO2010006890A1 Azapyrenes for electronic applications |
| 01/21/2010 | WO2010006496A1 Compounds of estrogen-related receptor modulators and the uses thereof |
| 01/21/2010 | WO2010006438A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 01/21/2010 | WO2009137130A3 Antibacterial fluoroquinolone analogs |
| 01/21/2010 | WO2009135651A8 6-pyridin-3-yl-3,4-dihydro-1h-quinolin-2-one derivatives and related compounds as inhibitors of the human aldosterone synthase cyp11b2 |
| 01/21/2010 | WO2009112677A3 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/21/2010 | WO2009089076A4 Processes for the preparation and purification of paliperidone palmitate |
| 01/21/2010 | WO2009046841A8 Piperidine and piperazine derivatives for treating tumours |
| 01/21/2010 | US20100016595 Process for preparing (s)-(+)-clopidogrel base and its salts |
| 01/21/2010 | US20100016594 Process for the preparation of clopidogrel and its pharmaceutically acceptable salts |
| 01/21/2010 | US20100016578 Macrocyclic serine protease inhibitors |
| 01/21/2010 | US20100016383 4-(3,3-dihalo-allyloxy)phenol derivatives having pesticidal properties |
| 01/21/2010 | US20100016341 Aspartyl protease inhibitors containing a tricyclic ring system |
| 01/21/2010 | US20100016307 Novel compounds |
| 01/21/2010 | US20100016303 Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 01/21/2010 | US20100016301 6-Dimethylamino-2-(2-hydroxymethyl-3-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-imidazo[1,2-b]pyridazin-6-yl }-phenyl)-3,4-dihydro-2H-isoquinolin-1-one; asthma, lupus ; inhibit Btk |
| 01/21/2010 | US20100016281 Pyrimidine compounds as serotonin receptor modulators |
| 01/21/2010 | US20100016277 Diazabicyclic central nervous system active agents |
| 01/21/2010 | US20100016233 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues |
| 01/21/2010 | US20100011656 Use of rylenes as markers for liquids |
| 01/21/2010 | CA2739379A1 Compounds as the estrogen-related receptor modulators and the uses thereof |
| 01/21/2010 | CA2731130A1 Pyridazine derivatives as smo inhibitors |
| 01/21/2010 | CA2730964A1 Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730890A1 Thiosemicarbazone inhibitor compounds and cancer treatment methods |
| 01/21/2010 | CA2730749A1 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors |
| 01/21/2010 | CA2730593A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 01/21/2010 | CA2730516A1 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 01/21/2010 | CA2730493A1 Modulators of acetyl-coenzyme a carboxylase and methods of use thereof |
| 01/21/2010 | CA2730397A1 Substituted indolyl and indazolyl derivatives and uses thereof |
| 01/21/2010 | CA2729986A1 New chemical compounds |
| 01/21/2010 | CA2729965A1 Fused heterocyclyc inhibitor compounds |
| 01/21/2010 | CA2729606A1 Alpha7 nicotinic acetylcholine receptor inhibitors |
| 01/21/2010 | CA2726460A1 Novel phenyl-imidazopyridines and pyridazines |
| 01/20/2010 | EP2145887A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and use thereof |
| 01/20/2010 | EP2145878A2 Aurora Kinase inhibitors |
| 01/20/2010 | EP2145877A2 Aurora Kinase inhibitors |
| 01/20/2010 | EP2144909A1 [2, 6]naphthyridines useful as protein kinase inhibitors |
| 01/20/2010 | EP2144908A1 2, 6-naphthyridine derivatives as protein kinase modulators |
| 01/20/2010 | EP2144902A1 [6,6]and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| 01/20/2010 | EP2144885A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors |
| 01/20/2010 | EP1805141B1 Piperidines and related compounds for treatment of alzheimer's disease |
| 01/20/2010 | EP1615647B1 Pharmaceutical use of fused 1,2,4-triazoles |
| 01/20/2010 | CN101631787A Tricyclic isoquinoline derivatives for treatment of obesity |
| 01/20/2010 | CN101631786A 新颖的jnk抑制剂 Jnk novel inhibitors |
| 01/20/2010 | CN101628913A Compound as estrogen-related receptor modulator and application thereof |
| 01/20/2010 | CN100582109C Polycyclic agents for the treatment of respiratory syncytial virus infections |